Hims & Hers Health [HIMS] vs Procter & Gamble [PG] Detailed Stock Comparison

Hims & Hers Health, Inc.

NYSE
Loading...

Procter & Gamble Co.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Hims & Hers Health, Inc. wins in 4 metrics, Procter & Gamble Co. wins in 16 metrics, with 0 ties. Procter & Gamble Co. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Hims & Hers Health, Inc. Procter & Gamble Co. Better
P/E Ratio (TTM) 55.20 21.55 Procter & Gamble Co.
Price-to-Book Ratio 11.83 6.48 Procter & Gamble Co.
Debt-to-Equity Ratio 207.16 68.72 Procter & Gamble Co.
PEG Ratio -2.21 -3.48 Hims & Hers Health, Inc.
EV/EBITDA 39.62 14.76 Procter & Gamble Co.
Profit Margin (TTM) 5.47% 19.30% Procter & Gamble Co.
Operating Margin (TTM) 2.72% 26.30% Procter & Gamble Co.
EBITDA Margin (TTM) 2.72% 26.30% Procter & Gamble Co.
Return on Equity 25.23% 31.56% Procter & Gamble Co.
Return on Assets (TTM) 5.29% 10.90% Procter & Gamble Co.
Free Cash Flow (TTM) $57.42M $14.04B Procter & Gamble Co.
Dividend Yield N/A 2.82% N/A
1-Year Return -51.66% -6.66% Procter & Gamble Co.
Price-to-Sales Ratio (TTM) 2.73 3.99 Hims & Hers Health, Inc.
Enterprise Value $6.96B $365.49B Procter & Gamble Co.
EV/Revenue Ratio 2.97 4.29 Hims & Hers Health, Inc.
Gross Profit Margin (TTM) 71.94% 51.22% Hims & Hers Health, Inc.
Revenue per Share (TTM) $10 $36 Procter & Gamble Co.
Earnings per Share (Diluted) $0.51 $6.76 Procter & Gamble Co.
Beta (Stock Volatility) 2.32 0.40 Procter & Gamble Co.
Short % of Float 38.71% 1.16% Procter & Gamble Co.

Hims & Hers Health, Inc. vs Procter & Gamble Co. Stock Performance Analysis

Loading Price Chart...

HIMS
PG

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hims & Hers Health, Inc.12.49%11.04%20.44%21.26%-16.77%-9.70%
Procter & Gamble Co.0.57%3.69%6.28%-1.09%3.67%6.11%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hims & Hers Health, Inc.-51.66%210.06%141.62%173.67%173.67%173.67%
Procter & Gamble Co.-6.66%0.05%13.32%79.97%131.27%171.92%

Performance & Financial Health Analysis: Hims & Hers Health, Inc. vs Procter & Gamble Co.

MetricHIMSPG
Market Information
Market Cap i$6.42B$340.49B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i45,043,7138,663,698
90 Day Avg. Volume i34,338,94110,318,083
Last Close$30.17$150.46
52 Week Range$13.74 - $70.43$137.62 - $167.25
% from 52W High-57.16%-10.04%
All-Time High$72.98 (Feb 17, 2025)$180.43 (Nov 25, 2024)
% from All-Time High-58.66%-16.61%
Growth Metrics
Quarterly Revenue Growth0.28%0.02%
Quarterly Earnings Growth-0.21%-0.07%
Financial Health
Profit Margin (TTM) i0.05%0.19%
Operating Margin (TTM) i0.03%0.26%
Return on Equity (TTM) i0.25%0.32%
Debt to Equity (MRQ) i207.1668.72
Cash & Liquidity
Book Value per Share (MRQ)$2.38$22.49
Cash per Share (MRQ)$2.53$4.66
Operating Cash Flow (TTM) i$300.01M$19.07B
Levered Free Cash Flow (TTM) i$110.51M$13.25B
Dividends
Last 12-Month Dividend Yield iN/A2.82%
Last 12-Month Dividend iN/A$4.24

Valuation & Enterprise Metrics Analysis: Hims & Hers Health, Inc. vs Procter & Gamble Co.

MetricHIMS (Apr 24, 2026)PG (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i55.2021.55
Forward P/E i19.8320.23
PEG Ratio i-2.21-3.48
Price to Sales (TTM) i2.733.99
Price to Book (MRQ) i11.836.48
Market Capitalization
Market Capitalization i$6.42B$340.49B
Enterprise Value i$6.96B$365.49B
Enterprise Value Metrics
Enterprise to Revenue i2.974.29
Enterprise to EBITDA i39.6214.76
Risk & Other Metrics
Beta i2.320.40
Book Value per Share (MRQ) i$2.38$22.49

Financial Statements Comparison: Hims & Hers Health, Inc. vs Procter & Gamble Co.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHIMS (2025)PG (2025)
Revenue/Sales i2.35B84.28B
Cost of Goods Sold i614.26M41.16B
COGS % of Revenue i26.2%48.8%
Gross Profit i1.73B43.12B
Gross Margin i73.8%51.2%
Research & Development i149.30MN/A
Operating Income (EBIT) i105.61M20.45B
Operating Margin i4.5%24.3%
EBITDA i155.68M23.92B
EBITDA Margin i6.6%28.4%
Pre-Tax Income i123.92M20.17B
Pre-Tax Income % of Revenue i5.3%23.9%
Income Tax i-4.44M4.10B
Income Tax % of Revenue i-0.2%4.9%
Net Income (Profit) i128.37M16.07B
Profit Margin i5.5%19.1%

Balance Sheet & Liquidity Metrics

MetricHIMS (2025)PG (2025)
Cash & Equivalents i228.62M9.56B
Total Current Assets i767.64M25.39B
Total Current Assets % of Revenue i32.7%30.1%
Total Current Liabilities i404.43M36.06B
Total Current Liabilities % of Revenue i17.2%42.8%
Long-Term Debt i1.12B25.70B
Long-Term Debt % of Revenue i47.5%30.5%
Total Shareholders Equity i540.93M52.28B
Retained Earnings i-113.77M129.97B
Retained Earnings % of Revenue i-4.8%154.2%
Property, Plant & Equipment i351.33M0

Cash Flow Statement Comparison

MetricHIMS (2025)PG (2025)
Operating Cash Flow i400.85M17.06B
Operating Cash Flow % of Revenue i17.1%20.2%
Capital Expenditures i-226.05MN/A
Free Cash Flow i57.42M14.04B
FCF Margin i2.4%16.7%
Debt Repayment iN/A-9.63B
Common Stock Repurchase i-89.96M-6.50B

Short Interest & Institutional Ownership Analysis

MetricHIMSPG
Shares Short i71.36M26.89M
Short Ratio i1.972.35
Short % of Float i38.71%1.16%
Shares Outstanding i227.25M2.32B
Float Shares i207.36M2.32B
% Held by Insiders i5.48%0.07%
% Held by Institutions i85.92%70.33%
% Held by Public i8.60%29.60%

Dividend Analysis & Yield Comparison: Hims & Hers Health, Inc. vs Procter & Gamble Co.

MetricHIMSPG
Last 12-Month Dividend iN/A$4.24
Last 12-Month Dividend Yield iN/A2.82%
3-Year Avg Annual Dividend iN/A$4.01
3-Year Avg Dividend Yield iN/A0.64%
3-Year Total Dividends iN/A$12.04
Ex-Dividend DateN/AJan 23, 2026